Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1996-07-10
1999-01-12
Cunningham, Thomas M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
4241851, 4242291, 435 693, 530350, 530395, 536 2372, A61K 4800, A61K 39245, C12N 1538, C07K 1403
Patent
active
058589899
ABSTRACT:
Recombinant subunit vaccines against bovine herpesvirus type 1 (BHV-1) are provided, as well as methods of vaccination and methods of recombinantly producing the subunit antigens or nucleotide sequences employed in the vaccines.
REFERENCES:
patent: 4335105 (1982-06-01), Gough
patent: 4341784 (1982-07-01), Kaplan et al.
patent: 4642333 (1987-02-01), Person
patent: 4661349 (1987-04-01), Kino et al.
patent: 4680176 (1987-07-01), Beins et al.
patent: 4709011 (1987-11-01), Cohen et al.
patent: 4724146 (1988-02-01), Kino et al.
patent: 5151267 (1992-09-01), Babiuk et al.
patent: 5585264 (1996-12-01), Babiuk et al.
Manickan, E. et al., Crit. Rev. Immunol. 17:139-154, "DNA Vaccines --a modern gimmick or a boon to vaccinology?", 1997.
Wolff et al.., Science 247:1465, 1990.
Robinson et al., Vaccine 11:975-, 1990.
Ulmer et al., Science 254:1745-, 1993.
Babiuk et al. (1975) Infect. Immun. 12:958-963.
Misra et al. (1981) J. Virol. 40:367-378.
van Drunen Littel-van den Hurk et al. (1984) Virology 135:466-479.
van Drunen Littel-van den Hurk et al. (1985) Virology 144:216-227.
Collins et al. (1984) J. Virol. 52:403-409.
Okazaki et al. (1986) Virology 150:260-264.
van Drunen Littel-van den Hurk et al. (1985) Virology 144:204-215.
van Drunen Littel-van den Hurk et al. (1986) J. Clin. Microbiol. 23:274-282.
Okazaki et al. (1987) Arch. Virol. 92:17-26.
Mayfield et al. (1983) J. Virol. 47:259-264.
Pachl et al. (1987) J. Virol. 61:315-325.
Babiuk et al. (1987) Virology 159:57-66.
Lupton et al. (1980) Am. J. Vet. Res. 41:383-390.
Cox et al., "Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA" J. Virology (1993) 67:5664-5667.
Hammerschmidt et al., "Common epitopes of glycoprotein B map within the major DNA-binding proteins of bovine herpesvirus type 2 (BHV-2) and herpes simplex virus type 1 (HVS-1)" Virology (1988) 165:408-418.
Lawrence et al., "Map location of the gene for a 130,000-dalton glycoprotein of bovine herpesvirus 1" J. Virol. (1986) 60:405-414.
Liang et al., "An in vivo study of a glycoprotein gill-negative bovine herpesvirus 1 (BHV-1) mutant expressing B-galactosidase: evaluation of the role of gill in virus infectivity and its use as a vector for mucosal immunization" Virology (1992) 189:629-639.
Misra et al., "Sequence of a bovine herpesvirus type-1 glycoprotein gene that is homologous to the herpes simplex gene for glycoprotein g.beta." Virology (1988) 166:542-549.
van Drunen Littel-van den hurk et al., "Synthesis and processing of bovine herpesvirus 1 glycoproteins" J. Virology (1986) 59:401-410.
van Drunen Littel-van den Hurk et al., "Epitope specificity of the protective immune response induced by individual bovine herpesvirus-1 glycoproteins" Vaccine (1990) 8:358-368.
Leary et al., "Recombinant herpesviral proteins produced by cell-free translation provide a novel approach for the mapping of T lymphocyte epitopes" J. Immunol. (1990) 145:718-723. (Medline accession No. 07401317).
Leary et al., "Constitutively expressing cell lines that secrete a truncated bovine herpes virus-1 glycoprotein (gpl) stimulates T-lymphocyte responsiveness" Immunology (1992) 76:3673-3672.
Palmer et al., "Bovine natural killer-like cell responses against cell lines expressing recombinant bovine herpesvirus type 1 glycoproteins" J. Innumol. (1990) 145:1009-1014.
Babiuk et al., "Protection of cattle from bovine herpesvirus type 1 (BHV-1) infection by immunization with individual viral glycoproteins" Virol. (1987) 159:57-66.
Collins et al., "Neutralizing determinants defined by monoclonal antibodies on polypeptides specified by bovine herpesvirus 1" J. Virol. (1984) 52:403-409.
Fitzpatrick et al., "Expression of bovine herpesvirus 1 glycoproteins gl and glll in transfected murine cells" J. Virol. (1988) 62:4239:4248.
Fitzpatrick et al., "Mapping of 10 epitopes on bovine herpesvirus type, glycoproteins gl and glll" Virol. (1990) 176:145-157.
Gerber et al., "Local and systemic cellular and antibody immune responses of cattle to infectious bovine rhinotracheitis virus vaccines administered intranasally or intramuscularly" Am. J. Vet. Res. (1978) 39:753-760.
Hughes et al., "Functional and topographical analyses of epitopes on bovine herpesvirus type 1 glycoprotein IV" Arch. Virol. (1988) 103:47-60.
Jericho et al., "The effect of dose, route and virulence of bovine herpesvirus 1 vaccine on experimental respiratory disease in cattle" Can. J. Com. Med. (1983) 47:133-139.
Mayfield et al., "Cloning and cleavage site mapping of DNA from bovine herpesvirus 1 (Cooper Strain)" J. Virol. (1983) 47:259-264.
Misra et al., "Proteins specified by bovine herpesvirus 1(Infectious Bovine Rhinotracheitis Virus)" J. Virol. (1981) 40:367-378.
Okazaki et al., "Mechanisms of neutralization by monoclonal antibodies to different antigenic sites on the bovine herpesvirus type 1 glycoproteins" Virology (1986) 150:260-264.
Pachl et al., "Expression of cell-associated and secreted forms of herpes simplex virus Type 1 glycoprotein gB in mammalian cells" J. Virol. (1987) 61:315-325.
Pastoret et al., "Reactivation of temperature-sensitive and non-temperature sensitive infectious bovine rhinotracheitis vaccine virus with dexamethasone" Infect. Immun. (1980) 29:483-488.
Tikoo et al., "Molecular cloning, sequencing, and expression of functional bovine herpesvirus 1 glycoprotein gIV in transfected bovine cells" J. Virol. (1990) 64:5132-5142.
van Drunen Littel-van den Hurk et al., "Interactions of monoclonal antibodies and bovine herpesvirus type 1 (BHV-1) glycoproteins: characterization of their biochemical and immunological properties" Virology (1984) 135:466-479.
van Drunen Littel-van den Hurk et al., "Antigenic and immunogenic characteristics of bovine herpesvirus type-1 glycoproteins GVP 3/9 and GVP 6/11a/16, urified by immunoadsorbent chromatography" Virology (1985) 144:204-215.
van Drunen Littel-van den Hurk et al., "Topographical analysis of bovine herpesvirus type-1 glycoproteins: use of monoclonal antibodies to identify and characterize functional epitopes" Virology (1985) 144:216-227.
van Drunen Littel-van den Hurk et al., "Polypeptide specificity of the antibody response after primary and recurrent infection with bovine herpesvirus 1" J. Clin. Microbiol. (1986) 23:274-282.
van Drunen Littel-van den Hurk et al., "Synthesis, cellular location, and immunogenicity of bovine herpesvirus 1 glycoproteins gI and gIII expressed by recombinant vaccinia virus" J. Virol. (1989) 63:2159-2168.
van Drunen Littel-van den Hurk et al., "Expression of bovine herpesvirus 1 glycoprotein gIV by recombinant baculovirus and analysis of its immunogenic properties" J. Virol. (1991) 65:263-271.
Babiuk Lorne
Fitzpatrick David
van der Hurk Sylvia
Zamb Tim
Cunningham Thomas M.
University of Saskatchewan
LandOfFree
Vaccines comprising nucleotide sequences encoding bovine herpesv does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccines comprising nucleotide sequences encoding bovine herpesv, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccines comprising nucleotide sequences encoding bovine herpesv will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1516094